Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson u.S. Retail Sales — Pharmacies & Drug Stores, Not Seasonally Adjusted ($M) (MRTSSM44611USN) ($M)
FRED (MRTSSM44611USN)
Latest, FY2025
404,300
Period ended Dec 28, 2025
Change on a year earlier
+8.6%
372,264 in FY2024
History
10 years
Since FY2016
Sources
1
FRED (MRTSSM44611USN)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Retail Sales — Pharmacies & Drug Stores, Not Seasonally Adjusted ($M) (MRTSSM44611USN) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 404,300 | +8.6% | FRED (MRTSSM44611USN) ↗ |
| FY2024 | Dec 29, 2024 | 372,264 | +8.4% | FRED (MRTSSM44611USN) ↗ |
| FY2023 | Dec 31, 2023 | 343,553 | +6.3% | FRED (MRTSSM44611USN) ↗ |
| FY2022 | Jan 1, 2023 | 323,048 | +3.3% | FRED (MRTSSM44611USN) ↗ |
| FY2021 | Jan 2, 2022 | 312,714 | +6.0% | FRED (MRTSSM44611USN) ↗ |
| FY2020 | Jan 3, 2021 | 295,027 | +4.1% | FRED (MRTSSM44611USN) ↗ |
| FY2019 | Dec 29, 2019 | 283,352 | +2.3% | FRED (MRTSSM44611USN) ↗ |
| FY2018 | Dec 30, 2018 | 276,924 | +3.1% | FRED (MRTSSM44611USN) ↗ |
| FY2017 | Dec 31, 2017 | 268,659 | +2.3% | FRED (MRTSSM44611USN) ↗ |
| FY2016 | Jan 1, 2017 | 262,555 | – | FRED (MRTSSM44611USN) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson U.S. Retail Sales — Pharmacies & Drug Stores, Not Seasonally Adjusted ($M) (MRTSSM44611USN) ($M), annual FY2016–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/fred_rx_retail_nsa
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.